AuthorisedPhase I and Phase II (Integrated)- OtherInterventional

CAT-01

The CAT-01 trial is an important research study for women diagnosed with cervical cancer. It's an early-stage trial, which means researchers are carefully testing a new treatment for the first time in people. The main goals are to make sure the treatment is safe and to see if it has a positive effect on the cancer. This study is open to women who are 18 years old or older. Taking part in a trial like this can help doctors learn more about new ways to fight cervical cancer, potentially leading to better treatments in the future for many women. It's a key part of developing new medicines.

At a glance

Status

Authorised

Phase

Phase I and Phase II (Integrated)- Other

Sponsor

Karolinska Institutet

Enrolment target

Start

09 Mar 2026

Cervical carcinoma

What is this study about?

This research study, known as CAT-01, is focused on exploring new treatments for cervical cancer. Cervical cancer is a type of cancer that starts in the cervix, which is the lower part of the womb. Scientists and doctors are always working hard to find better and safer ways to treat this condition, and studies like CAT-01 are a crucial step in that process.

This particular study is in its early stages, often called Phase I and Phase II. This means that researchers are carefully giving a new treatment to people for the first time. The very first priority is to check how safe the new treatment is and what kind of side effects it might cause. Once they understand the safety, they also start to look at whether the treatment is showing any signs of helping the body fight the cancer.

By taking part in studies like CAT-01, volunteers play a vital role in medical progress. Their involvement helps researchers gather important information that can lead to the development of new and more effective medicines or therapies for cervical cancer. This ultimately benefits not just the participants, but also future patients around the world.

Key takeaways

This study is testing a new treatment for cervical cancer.
It's an early-stage trial (Phase I/II) focusing on safety and initial effectiveness.
Only women aged 18 or older with cervical cancer can consider joining.
Participation involves close monitoring by a medical team.
You can withdraw from the study at any point.
Your involvement helps advance cancer research.

Who may be eligible?

To be considered for the CAT-01 study, you need to be a woman who has been diagnosed with cervical cancer. The study is open to adults, meaning you must be at least 18 years old.

There might be other specific health requirements or conditions that you need to meet to join. These are put in place to ensure your safety during the study and to make sure the researchers can effectively learn from the results.

Your doctor will be able to go through all the detailed requirements with you to see if this study could be a suitable option.

Quick self-check

Are you a woman?
Have you been diagnosed with cervical cancer?
Are you 18 years old or older?
Are you able to attend appointments regularly if required?

This is a guide only — the research team will confirm whether you can take part.

What does participation involve?

The details of what taking part involves aren't fully described here, but generally, in an early-stage study like this, you would have regular visits to the clinic or hospital. These visits are important for the medical team to monitor your health closely and see how you are responding to the study treatment. This might include various tests, such as blood tests, scans, and physical examinations. You would receive the study medication as prescribed by the research team.

There would also be follow-up appointments after you finish the main treatment part of the study to continue monitoring your health and any long-term effects. The total length of your participation, including treatment and follow-up, would be clearly explained to you before you agree to join.

Potential risks and benefits

Taking part in a clinical trial may offer potential benefits, such as access to a new treatment before it's widely available. It also contributes to medical knowledge, which can help others in the future. However, there are also potential risks; new treatments can have side effects, and it's possible the new treatment may not work for everyone. Before joining, the study team will explain all known risks and discomforts. Remember, you have the right to withdraw from the study at any time, for any reason, without it affecting your usual medical care.

Locations (1)

—
Sweden

Common questions

What is cervical cancer?

Cervical cancer is a type of cancer that starts in the cervix, which is the lower part of the womb (uterus) that connects to the vagina.

What does 'Phase I and Phase II' mean?

These are early stages of clinical research. Phase I mainly checks if a new treatment is safe. Phase II looks at safety again, and also if the treatment shows signs of working.

Will I get the new treatment if I join?

If you are eligible and decide to join this study, you would receive the new treatment being tested, rather than a placebo or standard treatment, as this is how early-stage trials are designed.

Who can join this study?

This study is open to women aged 18 and over who have been diagnosed with cervical cancer. There are other specific health checks to ensure your safety and suitability.

What if I change my mind about taking part?

You are free to leave the study at any time, for any reason, and this will not affect your ongoing medical care.